Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Liraglutide, a Long-Acting Human Glucagon-Like Peptide-1 Analog, Given as Monotherapy Significantly Improves Glycemic Control and Lowers Body Weight Without Risk of Hypoglycemia in Patients With Type 2 Diabetes
PaperCitations, authors & open-access status
Liraglutide, a Long-Acting Human Glucagon-Like Peptide-1 Analog, Given as Monotherapy Significantly Improves Glycemic Control and Lowers Body Weight Without Risk of Hypoglycemia in Patients With Type 2 Diabetes is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 471 citations, 2007 year and bronze oa status.
471
Citations
2007
Year
bronze
OA Status